Reply

Scott H. Sicherer; Robert A. Wood; Donald Stablein; Robert Lindblad; A. Wesley Burks; Andrew H. Liu; Stacie M. Jones; David M. Fleischer; Donald Y.M. Leung; Hugh A. Sampson

doi:10.1016/j.jaci.2011.03.048

Reply

Scott H. Sicherer, Robert A. Wood, Donald Stablein, Robert Lindblad, A. Wesley Burks, Andrew H. Liu, Stacie M. Jones, David M. Fleischer, Donald Y.M. Leung, Hugh A. Sampson

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	249-250
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology
Volume	128
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2011.03.048
State	Published - Jul 2011

Access to Document

10.1016/j.jaci.2011.03.048

Cite this

@article{202804e326c54f1483ab6817d32e1e3d,

title = "Reply",

author = "Sicherer, {Scott H.} and Wood, {Robert A.} and Donald Stablein and Robert Lindblad and Burks, {A. Wesley} and Liu, {Andrew H.} and Jones, {Stacie M.} and Fleischer, {David M.} and Leung, {Donald Y.M.} and Sampson, {Hugh A.}",

note = "Funding Information: Disclosure of potential conflict of interest: S. H. Sicherer has consulted for the Food Allergy Initiative (FAI) and has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID). R. A. Wood has received research support from the NIH and is on the medical advisory board for the Food Allergy and Anaphylaxis Network (FAAN). D. Stablein has received research support from the NIH. A. W. Burks has consulted for ActoGeniX NV, Intelliject, McNeil Nutritionals, Novartis, Pfizer, and Schering-Plough; is a minority stockholder in Allertein and Mast Cell, Inc; has served on an advisory board for Dannon Co Probiotics and an expert panel for Nutricia; has received research support from NIH, FAAN, and the Wallace Research Foundation ; has provided legal consultation or expert witness testimony on the topic of food allergy; and is on the medical board of directors of FAAN. S. M. Jones has received research support from the National Peanut Board, NIH/NIAID, Dyax Corp, and FAI and is on the medical advisory board of FAAN and a steering committee for Sanofi-Aventis. D. M. Fleischer has received research support from the NIH/NIAID . D. Y. M. Leung has declared that he has no conflict of interest. H. A. Sampson has consulted for Allertein Therapeutics; has received research support from FAI and NIH/NIAID ; and is a consultant and scientific advisor for FAI and a medical advisor for FAAN. The rest of the authors have declared that they have no conflict of interest. ",

year = "2011",

month = jul,

doi = "10.1016/j.jaci.2011.03.048",

language = "English",

volume = "128",

pages = "249--250",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Reply

AU - Sicherer, Scott H.

AU - Wood, Robert A.

AU - Stablein, Donald

AU - Lindblad, Robert

AU - Burks, A. Wesley

AU - Liu, Andrew H.

AU - Jones, Stacie M.

AU - Fleischer, David M.

AU - Leung, Donald Y.M.

AU - Sampson, Hugh A.

N1 - Funding Information: Disclosure of potential conflict of interest: S. H. Sicherer has consulted for the Food Allergy Initiative (FAI) and has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID). R. A. Wood has received research support from the NIH and is on the medical advisory board for the Food Allergy and Anaphylaxis Network (FAAN). D. Stablein has received research support from the NIH. A. W. Burks has consulted for ActoGeniX NV, Intelliject, McNeil Nutritionals, Novartis, Pfizer, and Schering-Plough; is a minority stockholder in Allertein and Mast Cell, Inc; has served on an advisory board for Dannon Co Probiotics and an expert panel for Nutricia; has received research support from NIH, FAAN, and the Wallace Research Foundation ; has provided legal consultation or expert witness testimony on the topic of food allergy; and is on the medical board of directors of FAAN. S. M. Jones has received research support from the National Peanut Board, NIH/NIAID, Dyax Corp, and FAI and is on the medical advisory board of FAAN and a steering committee for Sanofi-Aventis. D. M. Fleischer has received research support from the NIH/NIAID . D. Y. M. Leung has declared that he has no conflict of interest. H. A. Sampson has consulted for Allertein Therapeutics; has received research support from FAI and NIH/NIAID ; and is a consultant and scientific advisor for FAI and a medical advisor for FAAN. The rest of the authors have declared that they have no conflict of interest.

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=79959814692&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2011.03.048

DO - 10.1016/j.jaci.2011.03.048

M3 - Letter

AN - SCOPUS:79959814692

SN - 0091-6749

VL - 128

SP - 249

EP - 250

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -